Skip to main content

Table 1 Correlations of FBXO28 expression level with PFS and OS in ovarian cancer patients at different clinical stages. *P < 0.05, **P < 0.01

From: FBXO28 promotes cell proliferation, migration and invasion via upregulation of the TGF-beta1/SMAD2/3 signaling pathway in ovarian cancer

Stages

PFS

OS

Case

HR (95%CI)

P value

case

HR (95%CI)

P value

1

96

1.57(0.54–4.53)

0.4

74

0.24(0.07–0.76)

0.0089**

2

67

0.62(0.27–1.45)

0.27

61

0.24(0.07–0.91)

0.024*

3

919

1.27(1.09–1.48)

0.0023**

1044

1.31(1.11–1.55)

0.0012**

4

162

1.57(1.05–2.37)

0.028*

176

1.56(1.05–2.31)

0.027*

ALL

1435

1.14(1.0-1.29)

0.044*

1656

1.18(1.03–1.35)

0.014*

Back to article page

BMC Cancer

ISSN: 1471-2407

Contact us